| P50 | author | Ana Sebastião | Q43269598 |
| | Joana E. Coelho | Q44036451 |
| | Luísa V. Lopes | Q44036463 |
| | Vânia L Batalha | Q47913888 |
| | Maria José Diógenes | Q51007253 |
| | Jorge S Valadas | Q57006695 |
| | Rui Gomes | Q57006710 |
| P2093 | author name string | Diana G Ferreira | |
| P2860 | cites work | Expression cloning of a human corticotropin-releasing-factor receptor | Q24311371 |
| | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
| | Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity | Q24672753 |
| | Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia | Q24673553 |
| | Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor | Q28584057 |
| | Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 |
| | Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins | Q32034918 |
| | Neuronal cell death: a demise with different shapes. | Q33547888 |
| | Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor | Q33785575 |
| | Adenosine in the central nervous system: release mechanisms and extracellular concentrations | Q33955930 |
| | Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures | Q34032447 |
| | Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress | Q34072557 |
| | Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function | Q34296896 |
| | Excitatory amino acids as a final common pathway for neurologic disorders. | Q34321926 |
| | Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats | Q34485914 |
| | The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. | Q34489136 |
| | Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. | Q34740438 |
| | Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway | Q35014590 |
| | Adenosine and brain function | Q36083482 |
| | Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study | Q42459669 |
| | Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease | Q43665736 |
| | Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. | Q43927127 |
| | Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition | Q44014265 |
| | Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. | Q44390057 |
| | Modulation of glutamate release and excitotoxicity by adenosine A2A receptors | Q44685015 |
| | Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine | Q44878434 |
| | Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. | Q44934002 |
| | Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system | Q45182767 |
| | Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat. | Q46018096 |
| | Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. | Q46423618 |
| | Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex | Q46574495 |
| | Different roles of adenosine A1, A2A and A3 receptors in controlling kainate-induced toxicity in cortical cultured neurons. | Q46596549 |
| | Neuroprotection by corticotropin releasing factor during hypoxia in rat brain | Q48259163 |
| | Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain | Q48309464 |
| | Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress | Q48488684 |
| | Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites | Q48708894 |
| | Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. | Q48736054 |
| | Extrahypothalamic distribution of CRF-like immunoreactivity in the rat brain | Q48984056 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1030-1040 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons | |
| P478 | volume | 123 | |